Rhenman & Partners Asset Management AB - RA PHARMACEUTICALS INC ownership

RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 66 filers reported holding RA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$5,771,000
-16.2%
244,000
+6.6%
0.72%
-4.6%
Q2 2019$6,886,000
+104.9%
229,000
+52.7%
0.76%
+92.9%
Q1 2019$3,360,000
+1515.4%
150,000
+283.5%
0.39%
+1411.5%
Q1 2018$208,000
-77.4%
39,115
-63.9%
0.03%
-79.2%
Q4 2017$922,000
-47.3%
108,451
-9.4%
0.12%
-43.9%
Q3 2017$1,748,000119,6970.22%
Other shareholders
RA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
NEA Management Company, LLC 6,138,797$288,094,00013.62%
RA Capital Management 4,858,260$227,998,0006.91%
HAVENS ADVISORS LLC 116,000$5,444,0004.77%
ALPINE ASSOCIATES MANAGEMENT INC. 2,115,600$99,286,0003.16%
SYQUANT CAPITAL SAS 129,690$6,086,0003.13%
BARDIN HILL MANAGEMENT PARTNERS LP 391,758$18,386,0003.02%
Kellner Capital, LLC 91,100$4,275,0002.71%
Telemetry Investments, L.L.C. 17,100$803,0002.68%
Versor Investments LP 1,002,649$47,054,0002.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,519,718$71,320,0002.28%
View complete list of RA PHARMACEUTICALS INC shareholders